Ilsung Pharm (003120) - Total Liabilities

Latest as of September 2025: ₩13.51 Billion KRW ≈ $9.16 Million USD

Based on the latest financial reports, Ilsung Pharm (003120) has total liabilities worth ₩13.51 Billion KRW (≈ $9.16 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Ilsung Pharm generate cash to assess how effectively this company generates cash.

Ilsung Pharm - Total Liabilities Trend (2013–2024)

This chart illustrates how Ilsung Pharm's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Ilsung Pharm to evaluate the company's liquid asset resilience ratio.

Ilsung Pharm Competitors by Total Liabilities

The table below lists competitors of Ilsung Pharm ranked by their total liabilities.

Company	Country	Total Liabilities
Ruentex Materials Co Ltd TW:8463	Taiwan	NT$6.94 Billion
EcoFirst Consolidated Bhd KLSE:3557	Malaysia	RM463.23 Million
Chateau International Development Co Ltd TW:2722	Taiwan	NT$930.14 Million
DORO AB ST:DORO	Sweden	Skr432.70 Million
Allcargo Gati Limited NSE:ACLGATI	India	Rs-8.76 Billion
RS Automation Co.Ltd KQ:140670	Korea	₩33.34 Billion
Kortek Corporation KQ:052330	Korea	₩81.00 Billion
Atinum Investment Co. Ltd KQ:021080	Korea	₩16.58 Billion

Liability Composition Analysis (2013–2024)

This chart breaks down Ilsung Pharm's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Ilsung Pharm (003120) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	23.07	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.04	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.03	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Ilsung Pharm's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Ilsung Pharm (2013–2024)

The table below shows the annual total liabilities of Ilsung Pharm from 2013 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩11.75 Billion ≈ $7.96 Million	-67.77%
2023-12-31	₩36.44 Billion ≈ $24.69 Million	-25.42%
2022-12-31	₩48.85 Billion ≈ $33.11 Million	+91.78%
2021-12-31	₩25.47 Billion ≈ $17.26 Million	+7.26%
2020-12-31	₩23.75 Billion ≈ $16.09 Million	-1.16%
2019-12-31	₩24.03 Billion ≈ $16.28 Million	+4.79%
2018-12-31	₩22.93 Billion ≈ $15.54 Million	-6.93%
2017-12-31	₩24.64 Billion ≈ $16.70 Million	+33.88%
2016-12-31	₩18.40 Billion ≈ $12.47 Million	-62.20%
2015-12-31	₩48.69 Billion ≈ $32.99 Million	-2.02%
2014-12-31	₩49.69 Billion ≈ $33.67 Million	-0.45%
2013-12-31	₩49.92 Billion ≈ $33.83 Million	--

About Ilsung Pharm

KO:003120 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$105.08 Million

₩155.06 Billion KRW

Market Cap Rank

#18993 Global

#1006 in Korea

Share Price

₩22750.00

Change (1 day)

-1.52%

52-Week Range

₩15800.00 - ₩28650.00

All Time High

₩31693.76